<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
61474-4298-9
</NDCCode>
<PackageDescription>
100 CAPSULE, LIQUID FILLED in 1 BOTTLE (61474-4298-9)
</PackageDescription>
<NDC11Code>
61474-4298-09
</NDC11Code>
<ProductNDC>
61474-4298
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Bexarotene
</NonProprietaryName>
<DosageFormName>
CAPSULE, LIQUID FILLED
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20200806
</StartMarketingDate>
<EndMarketingDate>
20250630
</EndMarketingDate>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Catalent Ontario Limited
</LabelerName>
<SubstanceName>
BEXAROTENE
</SubstanceName>
<StrengthNumber>
75
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
06-AUG-20
</StartMarketingDatePackage>
<EndMarketingDatePackage>
30-JUN-25
</EndMarketingDatePackage>
<SamplePackage/>
</NDC>